Gel was sold under eight different brand names.
If you use ultrasound gel regularly, you’ll want to pay attention to a recent recall from the U.S. Food & Drug Administration (FDA).
In an Aug. 4 announcement, the FDA recalled eight lots of Eco-Med Pharmaceuticals ultrasound gel, citing contamination.
As of publication time 15 patients have contracted confirmed bacterial infections from the Eco-Gel 200 ultrasound gel. Additional cases are suspected but have not been confirmed.
Eco-Gel advised its customers to immediately discontinue use of the product and return it, if possible.
“Eco-Med has initiated this recall and quarantine due to bacterial contamination in the affected lots of ultrasound gel with Burkholderia cepacia complex (Bcc),” officials said in the FDA notification. “The source(s) of the bacterial contamination is currently unknown. Eco-Med is conducting a comprehensive investigation to determine the root cause of this contamination and take all necessary corrective action.”
Affected patients can be asymptomatic, or they could develop a serious infection, such as bloodstream infections that can cause sepsis or death.
Eight Eco-Med lots have been recalled:
The lots were sold under these brand names in the United States:
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
August 1st 2025In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
August 1st 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.